T
Takeda Pharmaceutical Company Limited
Q3 2025 earnings expected
Quarter
Jul – Sep
Expected
November 14, 2025(ET)
One-time charge this quarter
GAAP is in the red, but excluding a one-time charge of about $1.5B, Adjusted EPS is $0.44 — core operations remain healthy.
One-time charges include impairment, litigation, and tax events. The score auto-adjusts for these GAAP losses.
Revenue
This quarter$7.5B
Analyst estimate$1.2T▼ -99.4%
Year ago (Sep '24)$8.2B▼ -8.1%
EPS
This quarter$0.44
Analyst estimate$10.50▼ -95.8%
Year ago (Sep '24)$0.44▲ +0.0%
Revenue Growth Trajectory
-1%YoY
Last 7 quarters